ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,834, issued on Sept. 16, was assigned to HELIOS MEDICAL VENTURES LLC (Dallas).
"Injection site targeting device" was invented by Ezekiel Fink (Dallas), Robert E. Hanes (Manvel, Texas), Joel Henry (Manvel, Texas) and Bruce Schroeder (Manvel, Texas).
According to the abstract* released by the U.S. Patent & Trademark Office: "An apparatus for targeting an injection site using anatomical landmarks includes a first landmark identifier, a second landmark identifier, and a targeting band. The targeting band is connected with the first landmark identifier at a first end and a second landmark identifier at a second end. At least a portion of the targeting band is linearly deformable. In ...